|
Hepatitis C virus (HCV) infection remains a serious health problem, and an estimated 170 million people are infected worldwide.
Hepatitis C is the principal cause of death from liver disease and is the one of the main indications for liver transplantation. The primary
goal in the treatment of HCV infection is to reduce mortality by preventing liver-related deaths associated with the development
of hepatocellular carcinoma and decompensated cirrhosis. PEGylated interferons, together with ribavirin, are currently the
standard of care for patients with chronic hepatitis C. This review discusses the current indications and standard treatment of hepatitis
C virus infection. (Korean J Med 77:275-281, 2009) |
PDF Links
Full text via DOI
Download Citation
